2Asoh N,Masaki H,Watanabe H,et al.Molecular characterization of the transmission between thecolonization of methicillin-resistant staphylococcus aureus to human and environmental contamination in geriatric long-term care wards.Intern Med,2005,44:41-45.
1[1]Scott K Fridkin.Increasing prevalence of antimicrobial resistance in intensive care units.Crit Care Med,2001,29[S]:N64-68.
2Rebecca L,Casrol C,Sanjay S,et al.Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome[].Diagnostic Microbiology and Infectious Disease.2000
3Schaison G,Graninger W,Bouza E.Teicoplanin in the treatment of serious infection[].Journal of Chemotherapy.2000
4Allen NE,Nicas TI.Mechanism of action of oritavancin and related glycopeptide antibiotics[].FEMS Microbiology Reviews.2003
5Wilson A.Comparative safety of teicoplanin and vancomycin[].International Journal of Antimicrobial Agents.1998
6Boger DL.Vancomycin, teicoplanin, and ramoplanin: synthetic and mechanistic studies[].Medicinal Research Reviews.2001
